Sort   by:  
 Page size 
UnknownRibavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study.
Not available
S-EPMC7102646 | biostudies-literature
UnknownEbola virus glycoprotein GP1-host cell-surface HSPA5 binding site prediction.
Not available
S-EPMC7154572 | biostudies-literature
UnknownSARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic.
Not available
S-EPMC7596835 | biostudies-literature
UnknownAnti-HCV, nucleotide inhibitors, repurposing against COVID-19.
Not available
S-EPMC7089605 | biostudies-literature
UnknownGRP78: A cell's response to stress.
Not available
S-EPMC7094232 | biostudies-literature
UnknownRecognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective.
Not available
S-EPMC8139235 | biostudies-literature
UnknownThe anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico.
Not available
S-EPMC7778578 | biostudies-literature
UnknownA possible role for GRP78 in cross vaccination against COVID-19.
Not available
S-EPMC7486427 | biostudies-literature
UnknownMolecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase.
Not available
S-EPMC8979119 | biostudies-literature
UnknownNovel sofosbuvir derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.
Not available
S-EPMC10754943 | biostudies-literature
Sort   by:  
 Page size